特納亞治療公司
US ˙ NasdaqGS ˙ US87990A1060

SecurityTNYA / Tenaya Therapeutics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership21,273 shares
Latest Disclosed Value $ 13,002
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 77.39% decrease in ownership of TNYA / Tenaya Therapeutics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 21,273 shares of Tenaya Therapeutics, Inc. (US:TNYA) valued at $13,002 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 94,093 shares of Tenaya Therapeutics, Inc.. This represents a change in shares of -77.39% during the quarter. The current value of the position is $15,489 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Tenaya Therapeutics EC US87990A1060 21,273 -72,820 -77.39 13 -75.47 0.0003
2025-05-28 2025-03-31 NP Tenaya Therapeutics EC US87990A1060 94,093 0 0.00 54 -60.45 0.0013
2025-02-25 2024-12-31 NP Tenaya Therapeutics EC US87990A1060 94,093 -15,887 -14.45 135 -36.79 0.0029
2024-11-26 2024-09-30 NP Tenaya Therapeutics EC US87990A1060 109,980 20,906 23.47 212 -23.19 0.0040
2024-08-26 2024-06-30 NP Tenaya Therapeutics EC US87990A1060 89,074 9,593 12.07 276 -33.49 0.0056
2024-05-28 2024-03-31 NP Tenaya Therapeutics EC US87990A1060 79,481 0 0.00 416 61.48 0.0087
2024-02-26 2023-12-31 NP Tenaya Therapeutics EC US87990A1060 79,481 0 0.00 258 27.23 0.0055
2023-11-28 2023-09-30 NP Tenaya Therapeutics EC US87990A1060 79,481 0 0.00 203 -56.65 0.0053
2023-08-25 2023-06-30 NP Tenaya Therapeutics EC US87990A1060 79,481 15,186 23.62 467 154.64 0.0111
2023-05-26 2023-03-31 NP Tenaya Therapeutics EC US87990A1060 64,295 17,110 36.26 183 94.68 0.0049
2023-02-24 2022-12-31 NP Tenaya Therapeutics EC US87990A1060 47,185 0 0.00 95 -30.88 0.0026
2022-11-25 2022-09-30 NP Tenaya Therapeutics EC US87990A1060 47,185 0 0.00 137 -48.68 0.0039
2022-08-25 2022-06-30 NP Tenaya Therapeutics EC US87990A1060 47,185 8,674 22.52 266 -41.50 0.0073
2022-05-26 2022-03-31 NP Tenaya Therapeutics EC US87990A1060 38,511 16,928 78.43 454 11.03 0.0106
2022-02-25 2021-12-31 NP Tenaya Therapeutics EC US87990A1060 21,583 2,304 11.95 409 2.51 0.0089
2021-11-24 2021-09-30 NP Tenaya Therapeutics EC US87990A1060 19,279 19,279 398 0.0088
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.